Driving patient centricity in a changing market
“It is more important than ever for Pharmaceutical companies to effectively communicate the value their medicines offer to patients, physicians and healthcare systems. That’s the only way to reach Regulatory approval and market access. Our expert teams help our Medical Affairs and Market Access clients to optimise how their organisations generate evidence, engage with evidence-based payer and HCP decision-making, and contribute to internal product strategy.”
Matthew Mcloughlin, Head of executive committee and Head of advisory services.
Our Medical services
Our trusted Medical team help clients deliver every form of clinical study evidence required to ensure successful regulatory improvement and market access.
We help clients gather, manage and share medical information to stakeholders inside and outside of their organisation.
Using our industry-leading market access and HEOR services, we help our clients demonstrate the value of the new drugs they have developed.